Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis

Published:2020-10 Issue: Volume:21 Page:61-68
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Khalid Sidra,Basulaiman Bassam Mohammed,Emack Jeffrey,Booth Christopher M.,Duran Ignacio,Robinson Andrew G.,Berman David,Smoragiewicz Martin^ORCID,Amir Eitan^ORCID,Vera-Badillo Francisco E.

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Molecular pathways of urothelial development and bladder tumorigenesis;Castillo-Martin;Uro Oncol,2010

2. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity;Knowles;Nat Rev Cancer,2015

3. Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study;Burger;Eur Urol,2008

4. Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas;Hernandez;J Clin Oncol,2006

5. FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer;Mhawech-Fauceglia;Eur J Surg Oncol,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic Alterations of Signaling and DNA Damage Repair Pathways in Non-Muscle Invasive Bladder Cancer;Cancer Investigation;2023-11-26

2. Regional gain and global loss of 5-hydroxymethylcytosine coexist in genitourinary cancers and regulate different oncogenic pathways;Clinical Epigenetics;2022-09-20